Comparison of the Efficacy of Topical Ibuprofen to Oral Ibuprofen in Adolescent Athletes

Sponsor
Akron Children's Hospital (Other)
Overall Status
Terminated
CT.gov ID
NCT00567528
Collaborator
(none)
60
1
2
35
1.7

Study Details

Study Description

Brief Summary

This study was made to compare the efficacy of topical ibuprofen in gel form with oral ibuprofen in the treatment of sub-acute soft tissue injuries while comparing the tolerability of the delivery methods

Condition or Disease Intervention/Treatment Phase
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Treatment
Official Title:
Comparison of the Efficacy of Topical Ibuprofen to Oral Ibuprofen in Adolescent Athletes
Study Start Date :
May 1, 2006
Actual Primary Completion Date :
Apr 1, 2009
Actual Study Completion Date :
Apr 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Other: 1

Active ibuprofen liposomal transdermal gel with placebo ibuprofen capsule

Drug: ibuprofen
Apply by rubbing into skin for 30 to 60 seconds active ibuprofen 10% gel, 0.5cc to skin over injured area 3 times a day and taking placebo capsules of ibuprofen 3 times a day 10-40mg/kg per day, not to exceed 1200mg per day for 2 weeks.

Other: 2

Placebo ibuprofen liposomal transdermal gel with active ibuprofen capsules

Drug: Ibuprofen
Apply by rubbing into skin for 30 to 60 seconds placebo ibuprofen 10% gel, 0.5cc to skin over injured area 3 times a day and taking active capsules of ibuprofen 3 times a day 10-40mg/kg per day, not to exceed 1200mg per day for 2 weeks.

Outcome Measures

Primary Outcome Measures

  1. Efficacy of Topical Ibuprofen to Oral Ibuprofen measured by numeric pain rating, swelling at injury site, and change in sports activity. [10 days to 8 weeks after initial injury or flare up]

Secondary Outcome Measures

  1. Compare the tolerability of the two delivery methods measured by side effects. [2 weeks after starting topical and oral ibuprofen]

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 19 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 12-19yo

  • soft tissue injury or flare up of soft tissue injury within 10 days to 8 weeks

Exclusion Criteria:
  • Known hypersensitivity to aspirin or any NSAID,

  • allergy to eggs or egg products

  • history of asthma, renal disease, GI disease, active or suspected bleeding peptic ulcer (past or present), anemia, hypertension, other systemic disease significantly affecting liver or renal function

  • serious injury within six months

  • currently on anticoagulants

  • pregnant or lactating females

  • active arthritis in affected limb

  • open wounds, infected skin or fractures

  • opioid use within 7 days

  • severe psychological disorder

  • prior topical medication applied to the painful region/area of study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sports Medicine Department at Akron Children's Hospital Akron Ohio United States 44308

Sponsors and Collaborators

  • Akron Children's Hospital

Investigators

  • Principal Investigator: Emmanuel O Adekunle, M.D., Akron Children's Hospital
  • Study Director: Joseph Congeni, M.D., Akron Children's Hospital
  • Principal Investigator: Cynthia Bennett, MSN, CNP, Akron Children's Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Eloise Lemon, M.D., Akron Children's Hospital
ClinicalTrials.gov Identifier:
NCT00567528
Other Study ID Numbers:
  • IRB #0600210
First Posted:
Dec 5, 2007
Last Update Posted:
Jan 14, 2015
Last Verified:
Jan 1, 2012
Keywords provided by Eloise Lemon, M.D., Akron Children's Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 14, 2015